Researchers find infiltrating lymphocytes tie to survival in patients with recurrent larynx cancer; findings suggest super-boosting the immune system before additional treatment.

A new study finds exceptional long-term survival when a single dose of chemotherapy selects patients for chemoradiation or surgery.

A new study identifies a biomarker that rises just before patients’ cancer comes back — which could provide a window for earlier treatment.

New research explores how a patient’s own immune system might help determine effective treatment options for head and neck cancer.